Clinical evidence has demonstrated that the tumor-specific isoform of FN, extradomain-B fibronectin (EDB-FN) is specifically overexpressed in the ECM of aggressive tumors, including breast tumors, thereby making EDB-FN a promising target for early detection and differential diagnosis of breast cancer (12–14). Here, FN1 is linked to breast neoplasm.